Telerehabilitation Physical Activity for Mild Cognitive Impairment
Trial Summary
What is the purpose of this trial?
Individuals with mild cognitive impairment are often physically inactive and at risk for progressing to dementia. Physical inactivity is considered a modifiable risk factor for dementia. Therefore, interventions must be developed to foster sustainable improvement in daily physical activity. To address this problem, our pilot study aims are directed at assessing the feasibility and preliminary improvement of physical activity following the use of a mobile-health technology physical activity behavior change intervention. Similar interventions have shown to be very effective in older adults without cognitive impairment. We specifically focus on the subtype of amnestic mild cognitive impairment since this subtype often progresses to Alzheimer's Disease, a leading cause of death in the US. Improving physical activity is one approach to reduce the progression to Alzheimer's Disease and subsequently lower mortality. To increase the impact of the intervention, participants with amnestic mild cognitive impairment will be recruited along with a primary caregiver (dyads). Thirty dyads will be recruited and randomized to either an intervention group (15 dyads) or usual care group (15 dyads). The intervention group will receive a 12-week mobile-health technology physical activity behavior change intervention structured to improve physical activity. The intervention is unique in the combination of established behavior change theories and techniques and remote delivery for individuals with amnestic mild cognitive impairment. This pilot study is designed to assess the feasibility of the intervention by examining participant and primary caregiver retention, intervention session attendance, intervention acceptability and safety, and qualitative perspectives. Secondly, this pilot study will assess preliminary improvement in physical activity (i.e., daily steps). Improvement will be determined based on significant changes in participants' daily steps observed via accelerometry post-intervention in the intervention group compared to the usual care control group. The results of this study will support future work (K-award and R01 submissions) to explore efficacy and larger-scale implementation to reach rural and underserved areas of Nebraska and beyond.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires that you have been on stable doses of medication for at least the previous 30 days before starting the study.
What data supports the effectiveness of the treatment Telerehabilitation Physical Activity Behavioral (TPAB) intervention for Mild Cognitive Impairment?
Research shows that telerehabilitation programs, like the GOAL Tele-R system, are feasible and well-received by patients with Mild Cognitive Impairment (MCI), with high adherence rates and positive feedback on cognitive, emotional, and physical benefits. This suggests that such programs can effectively engage patients in activities that may help prevent further cognitive decline.12345
Is telerehabilitation physical activity safe for humans?
How is the Telerehabilitation Physical Activity Behavioral (TPAB) intervention different from other treatments for mild cognitive impairment?
The TPAB intervention is unique because it uses technology like smartphones and videoconferencing to deliver physical activity programs remotely, allowing patients to engage in rehabilitation from home. This approach is particularly beneficial for older adults with mild cognitive impairment, as it provides a convenient and supportive way to improve their quality of life without needing to travel to a clinic.1391011
Eligibility Criteria
This trial is for pairs of individuals where one person has mild cognitive impairment (MCI) aged between 50-85, and their caregiver who is over 19. The patient should have a diagnosis of amnestic MCI, score within a specific range on a cognitive assessment test, not be very physically active, and be stable on medications. Both must speak English and have internet access.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 12-week mobile-health technology physical activity behavior change intervention
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Telerehabilitation physical activity behavioral (TPAB) intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Creighton University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator